Julia Elvin

7PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2026
Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?

|May 14, 2026
Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian Cancer.

|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

|Jul 30, 2024
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.

Debra L Richardson, Julia C F Quintanilha, Natalie Danziger

|Nov 29, 2022
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.

Daniel F Hayes, Roy S Herbst, Jonathan L Myles

|Nov 21, 2020
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.

Jeffrey S Ross, Ethan S Sokol, Holger Moch

Pageof 2

Frequent Collaborators

3 joint publications

Gerald Li

3 joint publications

Jeffrey S Ross

3 joint publications

Ryon P Graf

2 joint publications

Alexa B Schrock